Gene Therapy Shows Promise for Aggressive Lymphoma
By webmd.com
An experimental gene therapy for aggressive non-Hodgkin lymphoma beat back more than a third of cancers that seemed untreatable, the therapy's developers report.
Thirty-six percent of over 100 very ill lymphoma patients appeared disease-free six months after a single treatment, according to results released by the treatment's maker, Kite Pharma of Santa Monica, Calif.
These patients had not responded to usual treatments and had no other options, Kite said Tuesday in a news release.
Overall, more than four out of five patients with the blood cancer saw their cancer reduced by more than half for at least part of the study, the company said.
"This seems extraordinary ... extremely encouraging," one cancer specialist, Dr. Roy Herbst, told the Associated Press.
But Herbst, who is chief of medical oncology at Yale Cancer Center in New Haven, Conn., said longer follow-up is needed to see if the benefit continues.
Still, he said, "This certainly is something I would want to have available." Side effects, which had been a concern, seemed manageable in this study, he said.
The therapy -- called CAR-T cell therapy -- enables the patient's own blood cells to kill the cancer cells.
Lymphoma is a general term for cancers that begin in the lymph system. The lymph system is part of the immune system, which helps the body fight disease.
Here's how the treatment works: A patient's blood is filtered so immune cells called T-cells can be altered to contain a cancer-fighting gene. The cells are returned to the patient intravenously, and the cancer-targeting cells then multiply in the patient's body.
The U.S. National Cancer Institute developed the gene approach and licensed it to Kite. Now, Kite and another pharmaceutical giant, Novartis AG, are competing to gain approval of the treatment, according to the AP.
Kite reportedly intends to seek U.S. Food and Drug Administration approval this spring and approval in Europe later this year. It could be the first gene therapy approved in the United States, the news report noted.
Although the therapy appears to benefit a significant number of patients, it is not risk-free. Researchers believe two patients died of treatment-related causes, the AP reported.
Other side effects included anemia or other blood problems that were treated, and neurological problems such as sleepiness, confusion, tremor or difficulty speaking, which typically lasted only a few days, the wire service reported.
Overall, however, the therapy seems safe, according to Dr. Steven Rosenberg, chief of surgery branch at the National Cancer Institute. He was not involved with the study.
"It's a safe treatment, certainly a lot safer than having progressive lymphoma," Rosenberg told the AP. He said he has a patient who was treated this way who is still in remission seven years later.
The cost of such treatment hasn't been reported yet, but immune system therapies tend to be very expensive.
The results are scheduled for presentation at the American Association for Cancer Research conference in April. Until published in a peer-reviewed medical journal, the data and conclusions should be considered preliminary.
Source: http://www.webmd.com/cancer/lymphoma/news/20170228/gene-therapy-shows-promise-for-aggressive-lymphoma
Thursday, July 2, 2026
A Closer Look at Predpharmnet and Related Concerns
Talking with a pharmacist or physician is only the first step in understanding a new medication. Children are typically prescribed weight-based dosing under close medical supervision. Regular checkups allow a physician to adjust dosage based on how the body responds. Chronic conditions such as arthritis or asthma often call for longer treatment planning. Blood pressure can rise modestly during treatment, so routine monitoring is a sensible precaution. Keeping a symptom journal can help identify patterns and guide follow-up conversations with a doctor. Immune suppression is a known effect, which is why avoiding sick contacts is often advised. Those looking for more detail can review this PredPharmNet for practical guidance. Tracking symptoms in a simple log helps both patients and doctors evaluate progress. Combining certain drugs without medical guidance can increase the risk of unwanted interactions. Hydration and a balanced diet can support the body during a course of treatment. Pharmacists are a valuable resource for questions about timing, storage, and interactions. Short courses of steroid therapy are generally well tolerated by most adults. Sleep disruption is a frequently reported side effect, especially when doses are taken later in the day. Some conditions respond well to a short burst of treatment, while others need a longer tapering schedule. Physical therapy or gentle exercise can support recovery alongside medication. Mild swelling or water retention sometimes accompanies steroid use and usually resolves after tapering. Staying active within safe limits can help offset some of the physical side effects of treatment. Long-term use requires closer monitoring due to potential effects on bone density and blood sugar. Common side effects include appetite changes, mood shifts, and difficulty sleeping. For readers who want a deeper dive, this check the details covers the specifics in plain language. Skin conditions like eczema sometimes respond well to topical or short oral courses. Bone health can be affected by prolonged use, making calcium and vitamin D intake more important. A licensed pharmacist should always be available to answer questions about any online order. Preparation and open communication with a provider can make any treatment plan easier to follow.
Subscribe to:
Posts (Atom)